Cadila Healthcare submits press release

08 May 2020 Evaluate

Cadila Healthcare has informed that the company enclosed a Press Release dated May 8, 2020 titled ‘Zydus Cadila Launches Enzalutamide, making Prostate Cancer therapy highly affordable’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

913.85 -4.50 (-0.49%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×